Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 21, 2023

BUY
$41.91 - $50.48 $175,267 - $211,107
4,182 Added 142.88%
7,109 $354,000
Q3 2022

Nov 14, 2022

BUY
$40.9 - $50.42 $119,714 - $147,579
2,927 New
2,927 $121,000
Q2 2022

Aug 15, 2022

SELL
$42.98 - $49.77 $4,298 - $4,977
-100 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$46.28 - $52.75 $4,628 - $5,275
100 New
100 $5,000
Q2 2019

Aug 14, 2019

SELL
$35.73 - $41.39 $1.78 Million - $2.06 Million
-49,802 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$33.78 - $40.68 $150,354 - $181,066
-4,451 Reduced 8.2%
49,802 $2.02 Million
Q4 2018

Feb 15, 2019

BUY
$32.65 - $37.95 $1.77 Million - $2.06 Million
54,253 New
54,253 $1.85 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.5B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.